Lupin Debuts on TIME-Statista Sustainable Companies List at No. 318
Event summary
- Lupin ranked 318th among 750 companies in TIME-Statista's 2026 sustainability ranking, evaluated across 20+ indicators.
- One of 16 Indian firms included in the global list, reflecting progress in ESG integration.
- Company holds CDP 'A' ratings for Climate Change and Water Security, plus S&P Global CSA score of 91 (2025).
- Lupin operates 15 manufacturing sites and 7 research centers across over 100 markets.
The big picture
Lupin's inclusion in this elite sustainability cohort underscores the growing importance of ESG metrics in pharmaceutical valuation. As regulators tighten climate disclosure rules, the company's early-mover advantage in governance and transparency could provide a competitive edge in key markets like the U.S. and Europe. The recognition also signals investor appetite for sustainable healthcare providers capable of balancing cost efficiency with long-term environmental commitments.
What we're watching
- ESG Execution
- Whether Lupin can sustain its high ESG performance amid global pharma cost pressures.
- Regulatory Alignment
- How stricter sustainability reporting rules may impact Lupin's transparency efforts.
- Competitive Positioning
- The pace at which peers adopt similar ESG frameworks to match Lupin's ranking.
Related topics